Neovacs SA (France) Market Value
| ALNEV Stock | EUR 0.0002 0.0001 33.33% |
| Symbol | Neovacs |
Neovacs SA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neovacs SA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neovacs SA.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Neovacs SA on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Neovacs SA or generate 0.0% return on investment in Neovacs SA over 720 days. Neovacs SA is related to or competes with Biophytis, Biosynex, and Eurobio Scientific. Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmun... More
Neovacs SA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neovacs SA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neovacs SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 33.7 | |||
| Information Ratio | 0.0087 | |||
| Maximum Drawdown | 100.0 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 50.0 |
Neovacs SA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neovacs SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neovacs SA's standard deviation. In reality, there are many statistical measures that can use Neovacs SA historical prices to predict the future Neovacs SA's volatility.| Risk Adjusted Performance | 0.0208 | |||
| Jensen Alpha | 0.0946 | |||
| Total Risk Alpha | (3.60) | |||
| Sortino Ratio | 0.0061 | |||
| Treynor Ratio | 0.1783 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neovacs SA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neovacs SA Backtested Returns
Neovacs SA appears to be out of control, given 3 months investment horizon. Neovacs SA has Sharpe Ratio of 0.026, which conveys that the firm had a 0.026% return per unit of risk over the last 3 months. By analyzing Neovacs SA's technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please exercise Neovacs SA's Mean Deviation of 12.47, downside deviation of 33.7, and Risk Adjusted Performance of 0.0208 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Neovacs SA holds a performance score of 2. The company secures a Beta (Market Risk) of 1.87, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neovacs SA will likely underperform. Please check Neovacs SA's treynor ratio and the relationship between the semi variance and price action indicator , to make a quick decision on whether Neovacs SA's current price movements will revert.
Auto-correlation | 0.95 |
Excellent predictability
Neovacs SA has excellent predictability. Overlapping area represents the amount of predictability between Neovacs SA time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neovacs SA price movement. The serial correlation of 0.95 indicates that approximately 95.0% of current Neovacs SA price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.95 | |
| Spearman Rank Test | 0.97 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
Neovacs SA lagged returns against current returns
Autocorrelation, which is Neovacs SA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neovacs SA's stock expected returns. We can calculate the autocorrelation of Neovacs SA returns to help us make a trade decision. For example, suppose you find that Neovacs SA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neovacs SA regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neovacs SA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neovacs SA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neovacs SA stock over time.
Current vs Lagged Prices |
| Timeline |
Neovacs SA Lagged Returns
When evaluating Neovacs SA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neovacs SA stock have on its future price. Neovacs SA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neovacs SA autocorrelation shows the relationship between Neovacs SA stock current value and its past values and can show if there is a momentum factor associated with investing in Neovacs SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Neovacs Stock Analysis
When running Neovacs SA's price analysis, check to measure Neovacs SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neovacs SA is operating at the current time. Most of Neovacs SA's value examination focuses on studying past and present price action to predict the probability of Neovacs SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neovacs SA's price. Additionally, you may evaluate how the addition of Neovacs SA to your portfolios can decrease your overall portfolio volatility.